Clinical Trials Browser

Phase 2 × Carcinoma, Non-Small-Cell Lung × GRN163L peptide × Clear all

NCT01137968 2016-01-26

Imetelstat as Maintenance Therapy After Initial Induction Chemotherapy in Non-small Cell Lung Cancer (NSCLC)

Phase 2 Completed

Carcinoma, Non-Small-Cell Lung